|
Market Closed -
Nasdaq
21:00:00 17/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 49.28 USD | +1.11% |
|
+0.24% | +65.31% |
| 08-03 | TG Therapeutics, Inc. Raises Earnings Guidance for the Full Year 2026 | CI |
| 08-03 | TG Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
Stock exchange
Nasdaq
TGTX 49.28 $
+1.11%
52.38M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| TGTX | 49.28USD | +1.11% | 52.38M $ | |
CBOE
| TGTX | 49.33USD | +1.11% | 1.49M $ | |
|
Tradegate
| NKB2 | 42.60EUR | +0.95% | 6.39K € | |
|
London S.E.
| 0VGI | 56.70USD | +54.71% | 5.67K $ | |
|
Boerse Muenchen
| NKB2 | 43.00EUR | +0.47% | 1.94K € | |
|
Deutsche Boerse AG
| NKB2 | 42.00EUR | +0.72% | 0 € | |
|
Börse Stuttgart
| NKB2 | 41.70EUR | -1.65% | 0 € | |
|
Berne S.E.
| NKB2 | 40.09CHF | +2.02% | 0 CHF | |
|
Borsa Italiana
| 1TGTX | 41.80EUR | +4.24% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 52.68 | 59.06 | 57.12 |
| Spread/Res. | -6.45% | -16.56% | -13.73% |
| Spread/Supp. | +6.74% | +14.23% | +23.02% |
| Support | 46.17 | 43.14 | 40.06 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- TGTX Stock
- Charts TG Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
